These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 31267094

  • 1. Early response to the treatment of choroidal neovascularization complicating central serous chorioretinopathy: a OCT-angiography study.
    Sacconi R, Tomasso L, Corbelli E, Carnevali A, Querques L, Casati S, Bandello F, Querques G.
    Eye (Lond); 2019 Nov; 33(11):1809-1817. PubMed ID: 31267094
    [Abstract] [Full Text] [Related]

  • 2. ANTIANGIOGENICS IN CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH LASER IN CENTRAL SEROUS CHORIORETINOPATHY.
    Chhablani J, Pichi F, Silva R, Casella AM, Murthy H, Banker A, Nowilaty SR, Carrai P, Nucci P, Arevalo JF, King Khaled Eye Specialist Hospital International Collaborative Retina Study Group.
    Retina; 2016 May; 36(5):901-8. PubMed ID: 27115855
    [Abstract] [Full Text] [Related]

  • 3. Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy.
    Romdhane K, Zola M, Matet A, Daruich A, Elalouf M, Behar-Cohen F, Mantel I.
    Br J Ophthalmol; 2020 Jul; 104(7):910-916. PubMed ID: 31615761
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative efficacy of brolucizumab, half-dose photodynamic therapy, and aflibercept in managing chronic central serous chorioretinopathy.
    Huang YT, Tien PT, Chen PY, Yang CL, Chen SN.
    Graefes Arch Clin Exp Ophthalmol; 2024 Jun; 262(6):1755-1763. PubMed ID: 38224344
    [Abstract] [Full Text] [Related]

  • 9. Choroidal neovascularization secondary to half-dose photodynamic therapy for chronic central serous chorioretinopathy: A case report.
    Zhang Z, Bao X, Wu Z, Zhang J.
    Medicine (Baltimore); 2021 Feb 19; 100(7):e24790. PubMed ID: 33607835
    [Abstract] [Full Text] [Related]

  • 10. OCTA evaluation of treatment-naïve flat irregular PED (FIPED)-associated CNV in chronic central serous chorioretinopathy before and after half-dose PDT.
    Guo J, Tang W, Xu S, Liu W, Xu G.
    Eye (Lond); 2021 Oct 19; 35(10):2871-2878. PubMed ID: 33323982
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
    Sulzbacher F, Schütze C, Burgmüller M, Vécsei-Marlovits PV, Weingessel B.
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug 19; 257(8):1581-1590. PubMed ID: 31037488
    [Abstract] [Full Text] [Related]

  • 13. Intravitreal ziv-aflibercept for the treatment of choroidal neovascularisation associated with conditions other than age-related macular degeneration.
    Braimah IZ, Stewart M, Videkar C, Dedhia CJ, Chhablani J, ‘Ziv-aflibercept study group’.
    Br J Ophthalmol; 2017 Sep 19; 101(9):1201-1205. PubMed ID: 28119292
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. COMPARISON OF PHOTODYNAMIC THERAPY USING HALF-DOSE OF VERTEPORFIN OR HALF-FLUENCE OF LASER LIGHT FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Cheng CK, Chang CK, Peng CH.
    Retina; 2017 Feb 19; 37(2):325-333. PubMed ID: 27429374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.